AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2021
Sep 3, 2021
34931_dirs_2021-09-03_e957e551-a2ed-4d15-a200-66234219595d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2021-09-01
Reporting Person: Buck Kristen K (EVP, R&D and CMO)
More from LISATA THERAPEUTICS, INC.
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3
Annual Report
2026
Mar 12
Regulatory Filings
2026
Mar 9